secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hyperfine, Inc. (HYPR)
CIK:        0001833769
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0000950170-25-108030
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hyperfine Q2 revenue $2.7M (+26% QoQ), net loss $9.2M; FDA clearances for Optive AI and next-gen Swoop
--------------------------------------------------------------------------------

- Revenue $2.7M, up 26% from Q1; sold 8 commercial Swoop systems vs 6 in Q1.
- Net loss $9.2M ($0.12/share) vs $9.4M in Q1; gross margin 49.3%, up 800 bps QoQ.
- FDA cleared Optive AI software and next-generation Swoop system; commercial rollout begun.
- Completed neurology office pilot; full-scale commercial launch initiated.
- FY 2025 revenue guidance: 10-20% over 2024; cash burn guided to $27-29M, down 27% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833769/000095017025108030/0000950170-25-108030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833769/000095017025108030/hypr-20250813.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-108030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer